Recently Brainstorm-Cell Therapeutics recently announced it has its first patient enrollment in its Phase 2 study. A Phase 2 Open-label Multicenter Study to Evaluate the Safety and Efficacy of repeated administration of ® [Autologous Mesenchymal Stem Cells Secreting...